AIRLINK 74.45 Increased By ▲ 0.20 (0.27%)
BOP 5.09 Increased By ▲ 0.04 (0.79%)
CNERGY 4.43 Increased By ▲ 0.01 (0.23%)
DFML 38.37 Increased By ▲ 2.53 (7.06%)
DGKC 90.50 Increased By ▲ 2.50 (2.84%)
FCCL 22.74 Increased By ▲ 0.54 (2.43%)
FFBL 33.11 Increased By ▲ 0.39 (1.19%)
FFL 9.79 No Change ▼ 0.00 (0%)
GGL 10.95 Increased By ▲ 0.15 (1.39%)
HBL 116.30 Increased By ▲ 0.40 (0.35%)
HUBC 135.70 Decreased By ▼ -0.14 (-0.1%)
HUMNL 9.90 Increased By ▲ 0.06 (0.61%)
KEL 4.63 Increased By ▲ 0.02 (0.43%)
KOSM 4.79 Increased By ▲ 0.13 (2.79%)
MLCF 40.70 Increased By ▲ 0.82 (2.06%)
OGDC 138.25 Increased By ▲ 0.35 (0.25%)
PAEL 26.70 Increased By ▲ 0.27 (1.02%)
PIAA 26.24 Decreased By ▼ -0.04 (-0.15%)
PIBTL 6.65 Decreased By ▼ -0.11 (-1.63%)
PPL 123.34 Increased By ▲ 0.44 (0.36%)
PRL 26.90 Increased By ▲ 0.21 (0.79%)
PTC 14.15 Increased By ▲ 0.15 (1.07%)
SEARL 59.28 Increased By ▲ 0.58 (0.99%)
SNGP 71.20 Increased By ▲ 0.80 (1.14%)
SSGC 10.44 Increased By ▲ 0.08 (0.77%)
TELE 8.59 Increased By ▲ 0.03 (0.35%)
TPLP 11.30 Decreased By ▼ -0.08 (-0.7%)
TRG 64.83 Increased By ▲ 0.60 (0.93%)
UNITY 26.13 Increased By ▲ 0.08 (0.31%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 7,872 Increased By 34.2 (0.44%)
BR30 25,596 Increased By 136.3 (0.54%)
KSE100 75,227 Increased By 296.6 (0.4%)
KSE30 24,222 Increased By 76.1 (0.32%)

imageFRANKFURT: German kidney dialysis specialist Fresenius Medical Care (FMC) said investors may have to wait until 2016 for profit growth, as it cuts costs to counter pressure on reimbursement for dialysis treatments in the United States and amid a foray into new healthcare services.

FMC, which operates more than a third of the dialysis treatment centres in the United States, on Wednesday forecast net income to stagnate or grow by up to 5 percent in 2015 but to increase by 15-20 percent next year, based on current exchange rates prevailing at the beginning of 2015.

Analysts had on average hoped for net income growth of more than 12 percent this year and their expectations for an annual dividend of about 0.90 euros were also far ahead of FMC's proposed payout of 0.78 euros per share.

DZ Bank analyst Sven Kuerten described the outlook as rather disappointing; adding the forecast growth acceleration in 2016 "closes the gap to the estimates somewhat".

US state-run insurer Medicare changed the way it pays for medical services, giving clinic operators a financial incentive to reduce costs and use fewer drugs. Medicare no longer pays for individual services and drugs but instead makes lump-sum reimbursements per dialysis session.

In addition to cutting costs, FMC has embarked on buying a range of healthcare services companies in the so-called care coordination segment, seeking to offer a bundle of treatments for chronic kidney and cardiovascular disease to Medicare and private-sector insurers.

"The outlook reflects further operating cost investments within the Care Coordination segment for future growth," the company said.

Fourth-quarter net income of $335 million, down 4 percent, was broadly in line with analyst expectations.

German healthcare group Fresenius SE, which controls FMC, said separately it expected its adjusted net income to rise between 9 and 12 percent at constant currencies this year, helped by additional earnings from the purchase of new hospitals and demand for healthcare services.

Copyright Reuters, 2015

Comments

Comments are closed.